CD8A and infection: Hence, systemic inhibition of α4β1 integrin, by shaping neutrophil subsets accumulation in primary site of infection and secondary lymphoid organs and by increasing antigen-specific CD8 T-cell responses (Fig. 7), provides new opportunities for vaccine design.